Mobile health technology and chronic illness: what predicts user engagement with popular gout apps?

Not Applicable

Completed

• Conditions: Gout; Musculoskeletal - Other muscular and skeletal disorders; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12617001052325
• Lead Sponsor: The University of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-07-19
• Study Completion: 2018-08-05
• Last Update Posted: 10 March 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

Individuals will be eligible for inclusion in the intervention if they meet the following criteria: (1) a diagnosis of gout as defined by the 2015 ACR-EULAR Gout Classification Criteria, (2) a current prescription for urate lowering therapy, (3) > 18 years old, (4) ability to complete forms in English and provide informed consent, (5) own or have access to an iOS smartphone device capable of downloading apps.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ser engagement; examined by using a modified version of the Mobile Application Rating Scale (MARS) (Stoyanov, Hides, Kavanagh, Zelenko, Tjondronegoro & Mani, 2015)[Upon completion of the 2-week intervention];Usability and acceptability of the apps will also be examined qualitatively by asking a subset of participants (n=10 from each group) to attend an interview and/or focus group about their experience using the apps.[Upon completion of the 2-week intervention]

Secondary Outcome Measures

Name	Time	Method
Illness perceptions: Illness perceptions will be measured using a gout-specific Brief Illness Perceptions Questionnaire (Brief IPQ). The B-IPQ has satisfactory reliability and validity across a range of chronic illnesses (Broadbent, Petrie, Main, & Weinman, 2006).[Baseline and at completion of the 2-week intervention];Gout self-care activities: Adherence and self-care activities will be assessed with a self-report questionnaire which covers exercise, medication and diet-related activities over the past seven days. These items were adapted from a diabetes-specific Multidimensional Diabetes Questionnaire (Talbot, Nouwen, Gingras, Gosselin, & Audet, 1997) and have been used previously to assess self-care behaviours in gout (Dalbeth et al., 2012). This is a composite secondary outcome.[Baseline and at completion of the 2-week intervention]